• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素与肠道炎症性疾病:保护的分子机制。

Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection.

机构信息

Department of Pediatrics, Division of Neonatology, University of Oklahoma Health Sciences Center, 1200 North Everett Drive, ETNP7504, Oklahoma City, OK 73104, USA.

出版信息

Int J Mol Sci. 2019 Apr 18;20(8):1912. doi: 10.3390/ijms20081912.

DOI:10.3390/ijms20081912
PMID:31003422
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6514688/
Abstract

Intestinal inflammatory diseases, such as Crohn's disease, ulcerative colitis, and necrotizing enterocolitis, are becoming increasingly prevalent. While knowledge of the pathogenesis of these related diseases is currently incomplete, each of these conditions is thought to involve a dysfunctional, or overstated, host immunological response to both bacteria and dietary antigens, resulting in unchecked intestinal inflammation and, often, alterations in the intestinal microbiome. This inflammation can result in an impaired intestinal barrier allowing for bacterial translocation, potentially resulting in systemic inflammation and, in severe cases, sepsis. Chronic inflammation of this nature, in the case of inflammatory bowel disease, can even spur cancer growth in the longer-term. Recent research has indicated certain natural products with anti-inflammatory properties, such as curcumin, can help tame the inflammation involved in intestinal inflammatory diseases, thus improving intestinal barrier function, and potentially, clinical outcomes. In this review, we explore the potential therapeutic properties of curcumin on intestinal inflammatory diseases, including its antimicrobial and immunomodulatory properties, as well as its potential to alter the intestinal microbiome. Curcumin may play a significant role in intestinal inflammatory disease treatment in the future, particularly as an adjuvant therapy.

摘要

肠道炎症性疾病(如克罗恩病、溃疡性结肠炎和坏死性小肠结肠炎)的发病率正在不断上升。尽管目前对这些相关疾病的发病机制还不完全了解,但人们认为每种疾病都涉及宿主免疫功能失调或过度活跃,对细菌和饮食抗原均产生反应,导致肠道炎症失控,通常还会导致肠道微生物组发生改变。这种炎症会导致肠道屏障受损,允许细菌易位,可能导致全身炎症,在严重的情况下,还会导致败血症。在炎症性肠病的情况下,这种性质的慢性炎症甚至会刺激癌症的长期生长。最近的研究表明,某些具有抗炎特性的天然产物,如姜黄素,可以帮助控制肠道炎症性疾病所涉及的炎症,从而改善肠道屏障功能,并可能改善临床结果。在本文中,我们探讨了姜黄素对肠道炎症性疾病的潜在治疗特性,包括其抗菌和免疫调节特性,以及改变肠道微生物组的潜力。姜黄素在未来的肠道炎症性疾病治疗中可能发挥重要作用,特别是作为辅助治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef26/6514688/9ea27e0077d5/ijms-20-01912-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef26/6514688/3976a74c8321/ijms-20-01912-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef26/6514688/a16427a6f3e1/ijms-20-01912-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef26/6514688/9ea27e0077d5/ijms-20-01912-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef26/6514688/3976a74c8321/ijms-20-01912-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef26/6514688/a16427a6f3e1/ijms-20-01912-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef26/6514688/9ea27e0077d5/ijms-20-01912-g003.jpg

相似文献

1
Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection.姜黄素与肠道炎症性疾病:保护的分子机制。
Int J Mol Sci. 2019 Apr 18;20(8):1912. doi: 10.3390/ijms20081912.
2
Role of antibiotics for treatment of inflammatory bowel disease.抗生素在炎症性肠病治疗中的作用。
World J Gastroenterol. 2016 Jan 21;22(3):1078-87. doi: 10.3748/wjg.v22.i3.1078.
3
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.炎症、营养供应和共生微生物群在肠道病原体感染中的作用。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.
4
Effects of curcumin plus Soy oligosaccharides on intestinal flora of rats with ulcerative colitis.姜黄素联合大豆低聚糖对溃疡性结肠炎大鼠肠道菌群的影响
Cell Mol Biol (Noisy-le-grand). 2017 Aug 15;63(7):20-25. doi: 10.14715/cmb/2017.63.7.3.
5
Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.炎症性肠病中益生菌和抗生素治疗策略的基本原理。
Dig Dis. 2003;21(2):105-28. doi: 10.1159/000073243.
6
The Intestinal Microbiota in Inflammatory Bowel Disease.炎症性肠病中的肠道微生物群
ILAR J. 2015;56(2):192-204. doi: 10.1093/ilar/ilv030.
7
[Presence of intracellular Escherichia coli in patients with inflammatory bowel disease].炎症性肠病患者细胞内大肠杆菌的存在情况
Rev Med Chil. 2017 Sep;145(9):1129-1136. doi: 10.4067/s0034-98872017000901129.
8
Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.炎症性肠病中的抗生素与益生菌:为何使用、何时使用以及如何使用。
Curr Opin Gastroenterol. 2009 Jul;25(4):329-33. doi: 10.1097/MOG.0b013e32832b20bf.
9
Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study.姜黄素在小儿炎症性肠病中的耐受性:一项强制剂量滴定研究。
J Pediatr Gastroenterol Nutr. 2013 Mar;56(3):277-9. doi: 10.1097/MPG.0b013e318276977d.
10
Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets.炎症性肠病中的损伤相关分子模式:从生物标志物到治疗靶点。
World J Gastroenterol. 2018 Nov 7;24(41):4622-4634. doi: 10.3748/wjg.v24.i41.4622.

引用本文的文献

1
Targeting NLRP3 inflammasome with curcumin: mechanisms and therapeutic promise in chronic inflammation.用姜黄素靶向NLRP3炎性小体:慢性炎症中的机制及治疗前景
Inflammopharmacology. 2025 Sep 10. doi: 10.1007/s10787-025-01926-4.
2
A Randomized Double-Blind, Placebo-Controlled Trial of Artesunate and Curcumin in Patients With Crohn's Disease: A Pilot Study.青蒿琥酯与姜黄素治疗克罗恩病患者的随机双盲、安慰剂对照试验:一项初步研究
JGH Open. 2025 Jun 29;9(7):e70211. doi: 10.1002/jgh3.70211. eCollection 2025 Jul.
3
Impact of curcumin on gut microbiome.

本文引用的文献

1
Necrotizing Enterocolitis, Gut Microbiota, and Brain Development: Role of the Brain-Gut Axis.坏死性小肠结肠炎、肠道微生物群与脑发育:脑-肠轴的作用。
Neonatology. 2019;115(4):423-431. doi: 10.1159/000497420. Epub 2019 Apr 11.
2
Impact of curcumin on toll-like receptors.姜黄素对 Toll 样受体的影响。
J Cell Physiol. 2019 Aug;234(8):12471-12482. doi: 10.1002/jcp.28103. Epub 2019 Jan 8.
3
Blocking NF-κB Activation in Ly6c Monocytes Attenuates Necrotizing Enterocolitis.阻断 Ly6c 单核细胞中的 NF-κB 激活可减轻坏死性小肠结肠炎。
姜黄素对肠道微生物群的影响。
World J Exp Med. 2025 Mar 20;15(1):100275. doi: 10.5493/wjem.v15.i1.100275.
4
Treatment of Inflammatory Bowel Disease by Using Curcumin-Containing Self-Microemulsifying Delivery System: Macroscopic and Microscopic Analysis.使用含姜黄素的自微乳化给药系统治疗炎症性肠病:宏观与微观分析
Pharmaceutics. 2024 Oct 31;16(11):1406. doi: 10.3390/pharmaceutics16111406.
5
Supplementation of curcumin promotes the intestinal structure, immune barrier function and cecal microbiota composition of laying hens in early laying period.补充姜黄素可促进产蛋初期蛋鸡的肠道结构、免疫屏障功能和盲肠微生物群组成。
Poult Sci. 2024 Dec;103(12):104355. doi: 10.1016/j.psj.2024.104355. Epub 2024 Sep 24.
6
Ulcerative colitis: molecular insights and intervention therapy.溃疡性结肠炎:分子见解与干预治疗。
Mol Biomed. 2024 Oct 10;5(1):42. doi: 10.1186/s43556-024-00207-w.
7
Phase 1 clinical trial evaluating safety, bioavailability, and gut microbiome with a combination of curcumin and ursolic acid in lipid enhanced capsules.评估脂质增强胶囊中姜黄素与熊果酸组合的安全性、生物利用度和肠道微生物群的1期临床试验。
J Tradit Complement Med. 2024 Mar 7;14(5):558-567. doi: 10.1016/j.jtcme.2024.03.002. eCollection 2024 Sep.
8
Oral enzyme-responsive nanoprobes for targeted theranostics of inflammatory bowel disease.口腔酶响应型纳米探针用于炎症性肠病的靶向治疗。
J Nanobiotechnology. 2024 Aug 13;22(1):484. doi: 10.1186/s12951-024-02749-1.
9
The Modulatory Effects of Curcumin on the Gut Microbiota: A Potential Strategy for Disease Treatment and Health Promotion.姜黄素对肠道微生物群的调节作用:疾病治疗与健康促进的潜在策略
Microorganisms. 2024 Mar 23;12(4):642. doi: 10.3390/microorganisms12040642.
10
Herbal Medicines for the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis.草药治疗活动期溃疡性结肠炎:系统评价和荟萃分析。
Nutrients. 2024 Mar 23;16(7):934. doi: 10.3390/nu16070934.
Am J Pathol. 2019 Mar;189(3):604-618. doi: 10.1016/j.ajpath.2018.11.015. Epub 2018 Dec 27.
4
Innate and adaptive immunity in necrotizing enterocolitis.先天性和适应性免疫在坏死性小肠结肠炎中的作用。
Semin Fetal Neonatal Med. 2018 Dec;23(6):394-399. doi: 10.1016/j.siny.2018.08.002. Epub 2018 Aug 17.
5
Effects of Turmeric and Curcumin Dietary Supplementation on Human Gut Microbiota: A Double-Blind, Randomized, Placebo-Controlled Pilot Study.姜黄和姜黄素膳食补充剂对人体肠道微生物群的影响:一项双盲、随机、安慰剂对照的初步研究。
J Evid Based Integr Med. 2018 Jan-Dec;23:2515690X18790725. doi: 10.1177/2515690X18790725.
6
Oxidative Stress and Necrotizing Enterocolitis: Pathogenetic Mechanisms, Opportunities for Intervention, and Role of Human Milk.氧化应激与坏死性小肠结肠炎:发病机制、干预机会及人乳的作用。
Oxid Med Cell Longev. 2018 Jul 2;2018:7397659. doi: 10.1155/2018/7397659. eCollection 2018.
7
Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases?姜黄素能否用于治疗炎症性肠病?
J Med Food. 2018 Nov;21(11):1077-1085. doi: 10.1089/jmf.2017.0146. Epub 2018 Jun 29.
8
Intestinal Crosstalk between Microbiota and Serotonin and its Impact on Gut Motility.微生物群与血清素之间的肠道相互作用及其对肠道蠕动的影响。
Curr Pharm Biotechnol. 2018;19(3):190-195. doi: 10.2174/1389201019666180528094202.
9
Metabolic control of T cell immune response through glycans in inflammatory bowel disease.通过炎症性肠病中的糖基代谢控制 T 细胞免疫应答。
Proc Natl Acad Sci U S A. 2018 May 15;115(20):E4651-E4660. doi: 10.1073/pnas.1720409115. Epub 2018 May 2.
10
Monocyte activation and inflammation can exacerbate Treg/Th17 imbalance in infants with neonatal necrotizing enterocolitis.单核细胞激活和炎症可加重新生儿坏死性小肠结肠炎患儿 Treg/Th17 失衡。
Int Immunopharmacol. 2018 Jun;59:354-360. doi: 10.1016/j.intimp.2018.04.026. Epub 2018 Apr 19.